|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 89, 877-887, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
RA Guyton, LM Dorsey, JM Craver, DK Bone, EL Jones, DA Murphy and CR Hatcher Jr
Possible enhancement of myocardial protection by oxygenation of a
crystalloid cardioplegic solution was evaluated in a three-part study. In
Part I, canine hearts underwent ischemia followed by heterogeneous
cardioplegic arrest for 45 to 60 minutes. Oxygenation led to improved
recovery in the left anterior descending region (47% versus 86% recovery, p
less than 0.05) (15 minutes of ischemia) and in the circumflex region (9.5%
versus 52% recovery, p less than 0.05) (30 minutes of ischemia). Part II
was a blind prospective randomized study in 12 patients. It examined
creatine kinase, myoglobin, and lactate as well as coronary sinus flow,
oxygen consumption, and cardiac work 1 hour after aortic cross-clamping
during atrial and during ventricular pacing. No significant difference was
demonstrable between control and oxygenated solutions. In Part III, 57
coronary bypass patients were protected with a nonoxygenated solution while
94 patients received an identical oxygenated solution. Twelve-hour creatine
kinase levels were similar in the nonoxygenated (9.5 +/- 16 IU, +/-
standard deviation) and oxygenated (11 +/- 22 IU) groups if the cross-clamp
interval was 28 minutes or less. In patients subjected to longer than 28
minutes of arrest, the 12 hour creatine kinase MB levels were more than
twice as high in the nonoxygenated group (26.5 +/- 26 IU) compared to the
oxygenated group (9.9 +/- 14 IU, p less than 0.05). In this canine model of
heterogeneous cardioplegia and in the routine conduct of coronary bypass
operations, oxygenated crystalloid cardioplegia is superior to an identical
nonoxygenated solution.
ARTICLES
Improved myocardial recovery after cardioplegic arrest with an oxygenated crystalloid solution
This article has been cited by other articles:
![]() |
C. E Johnson, S. C Faulkner, J. Tucker, M. L Schmitz, R. B. Mee, and J. J Drummond-Webb Optimizing cardioplegia strategy for donor hearts Perfusion, January 1, 2004; 19(1): 65 - 68. [Abstract] [PDF] |
||||
![]() |
J. S. Shanewise, A. S. Kosinski, J. A. Coto, and E. L. Jones Prospective, randomized trial comparing blood and oxygenated crystalloid cardioplegia in reoperative coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1166 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Handy Jr., B. H. Dorman, M. J. Cavallo, R. B. Hinton, R. C. Roy, F. A. Crawford, and F. G. Spinale DIRECT EFFECTS OF OXYGENATED CRYSTALLOID OR BLOOD CARDIOPLEGIA ON ISOLATED MYOCYTE CONTRACTILE FUNCTION J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1064 - 1072. [Abstract] [Full Text] |
||||
![]() |
W. G. Hendren, D. D. O'Keefe, G. A. Geffin, A. G. Denenberg, T. R. Love, and W. M. Daggett Maximal oxygenation of dilute blood Cardioplegic solution Ann. Thorac. Surg., November 1, 1994; 58(5): 1558 - 1559. [Abstract] [PDF] |
||||
![]() |
H. B. Barner Blood cardioplegia: A review and comparison with crystalloid cardioplegia Ann. Thorac. Surg., December 1, 1991; 52(6): 1354 - 1367. [Abstract] [PDF] |
||||
![]() |
G. Staffan, P. Svenmarker, S. K Haggmark, and K E. Jansson A new method for crystalloid cardioplegic oxygenation Perfusion, April 1, 1991; 6(2): 93 - 97. [Abstract] [PDF] |
||||
![]() |
D. Wheeldon, R. Amar, and D. Bethune Oxygenated crystalloid cardioplegia: a new technique Perfusion, October 1, 1989; 4(4): 297 - 301. [PDF] |
||||
![]() |
M. J. Lynch, E. L. Bove, T. N. Zweng, M. H. Fox, S. F. Boiling, and K. P. Gallagher Protection of the Neonatal Heart Following Normothermic Ischemia: A Comparison of Oxygenated Saline and Oxygenated versus Nonoxygenated Cardioplegia Ann. Thorac. Surg., June 1, 1988; 45(6): 650 - 655. [Abstract] [PDF] |
||||
![]() |
K. G. Warner, M. Josa, M. D. Butler, P. C. Gherardi, S. N. Assousa, A. J. Saad, S. Siouffi, E. M. Barsamian, and S. F. Khuri Regional Changes in Myocardial Acid Production during Ischemic Arrest: A Comparison of Sanguineous and Asanguineous Cardioplegia Ann. Thorac. Surg., January 1, 1988; 45(1): 75 - 81. [Abstract] [PDF] |
||||
![]() |
R. A. Guyton, V. J. Maffei, J. M. Arcidi Jr., D. A. Langford, L. M. A. Dorsey, and C. R. Hatcher Jr. A Valveless Counterpulsation Left Ventricular Assist Pump in the Descending Aorta: Hemodynamic Benefit with a Reduced Risk of Cerebral Emboli Ann. Thorac. Surg., July 1, 1987; 44(1): 21 - 25. [Abstract] [PDF] |
||||
![]() |
W. G. Hendren, D. D. O'Keefe, G. A. Geffin, A. G. Denenberg, T. R. Love, and W. M. Daggett Maximal Oxygenation of Dilute Blood Cardioplegic Solution Ann. Thorac. Surg., July 1, 1987; 44(1): 48 - 52. [Abstract] [PDF] |
||||
![]() |
G. Noera, C. Massini, R. Lodi, and G. Baggio Normothermic blood cardioplegia reperfusion plus nifedipine after cardioplegic arrest: experimental study with a new delivery set Perfusion, July 1, 1987; 2(3): 185 - 194. [Abstract] [PDF] |
||||
![]() |
W. M. Daggett Jr., J. D. Randolph, M. Jacobs, D. D. O'Keefe, G. A. Geffin, L. A. Swinski, B. R. Boggs, and W. G. Austen The Superiority of Cold Oxygenated Dilute Blood Cardioplegia Ann. Thorac. Surg., April 1, 1987; 43(4): 397 - 402. [Abstract] [PDF] |
||||
![]() |
S. Slogoff, A. S. Keats, D. A. Cooley, G. J. Reul, O. H. Frazier, D. A. Ott, J. M. Duncan, and J. J. Livesay Addition of Papaverine to Cardioplegia Does Not Reduce Myocardial Necrosis Ann. Thorac. Surg., July 1, 1986; 42(1): 60 - 64. [Abstract] [PDF] |
||||
![]() |
G. Merin and N. H. Fishman Preparation of Oxygenated Cold Crystalloid Cardioplegic Solution Ann. Thorac. Surg., June 1, 1986; 41(6): 679 - 679. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |